RUSKI-201

N/A

Report date: 2023/04/20 09:43:31
NME

Base Information

Drug NameRUSKI-201
Drug Alias NameRUSKI-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-cysteine N-palmitoyltransferase HHAT inhibitors
TargetsProtein-cysteine N-palmitoyltransferase HHAT
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesImperial College London
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A